9 May 2023
Ropes & Gray Represents Advent International and Warburg Pincus in Acquisition of Baxter’s BioPharma Solutions for $4.25 Billion
Advising firms
Deal team
15 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Annie Sipe Lead | Ropes & Gray | Partner | private equity | Not stated |
| Christian Westra Lead | Ropes & Gray | Partner | private equity | Not stated |
| Matt Richards | Ropes & Gray | Partner | private equity | Not stated |
| Andrea Hwang | Ropes & Gray | Partner | finance | Not stated |
| Byung Choi | Ropes & Gray | Partner | finance | Not stated |
| David Saltzman | Ropes & Gray | Partner | tax | Not stated |
| Adam Greenwood | Ropes & Gray | Partner | tax | Not stated |
| Annie Herdman | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Ruchit Patel | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Samer Musallam | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Jim Dowden | Ropes & Gray | Partner | litigation & enforcement | Not stated |
| Lincoln Tsang | Ropes & Gray | Partner | life sciences regulatory & compliance | Not stated |
| Gregory Levine | Ropes & Gray | Partner | life sciences regulatory & compliance | Not stated |
| Amanda Austin | Ropes & Gray | Partner | life sciences | Not stated |
| Alison Fethke | Ropes & Gray | Counsel | health care | Not stated |
Stated terms
- Stated value
- USD 4.25bn ($4.25 billion)
- What the figure measures
- Total transaction value
- Client
- Advent International and Warburg PincusBuy-side
- Counterparties
- Baxter International Inc. (Sell-side)